Table 1. Table of clinicopathological features in different HPV status.
Variables | No. | HPV (−) | HPV (+) | p value |
---|---|---|---|---|
Gender | ||||
Male | 103 | 89 | 14 | 1.000 |
Female | 3 | 3 | 0 | |
Age | ||||
<60 y/o | 52 | 49 | 3 | 0.042* |
≥60 y/o | 54 | 43 | 11 | |
T classification | ||||
T1 and T2 | 74 | 64 | 10 | 1.000 |
T3 and T4a | 32 | 28 | 4 | |
N classification | ||||
Positive | 28 | 25 | 3 | 0.756 |
Negative | 78 | 67 | 11 | |
TNM stage | ||||
Stage I and II | 62 | 54 | 8 | 1.000 |
Stage III and IV | 44 | 38 | 6 | |
Extranodal extension | ||||
Positive | 16 | 15 | 1 | 0.560 |
Negative | 12 | 10 | 2 | |
Adjuvant RT/CCRT | ||||
Yes | 27 | 24 | 3 | 1.000 |
No | 79 | 68 | 11 | |
Tumor recurrence | ||||
Yes | 23 | 23 | 0 | 0.037* |
No | 83 | 69 | 14 | |
Second primary cancer | ||||
Yes | 18 | 15 | 3 | 0.703 |
No | 88 | 77 | 11 | |
Tumor differentiation | ||||
Well | 28 | 25 | 3 | 0.756 |
Moderate and poor | 78 | 67 | 11 | |
Tumor subsites | ||||
Transglottic | 11 | 11 | 0 | 0.117 |
Glottic | 54 | 47 | 7 | |
Supraglottic | 40 | 34 | 6 | |
Subglottic | 1 | 0 | 1 | |
Tobacco use | ||||
Smoking | 93 | 83 | 10 | 0.068** |
Non-smoking | 13 | 9 | 4 | |
Alcohol use | ||||
Drinking | 51 | 47 | 4 | 0.154 |
Non-drinking | 55 | 45 | 10 | |
Betel nut chewing | ||||
Chewing | 53 | 46 | 7 | 1.000 |
Non-chewing | 53 | 46 | 7 |
Notes.
- RT
- radiotherapy
- CCRT
- concurrent chemoradiotherapy
Statistical significance.
Marginal significance.